News|Videos|May 19, 2025

Compounded GLP-1 RA drugs: An introduction to the Alliance for Pharmacy Compounding

Fact checked by: Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Proponents of compounding pharmacy say it’s a necessary service that helps patients and physicians in the pursuit of good health. In this video series, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, introduces the organization, explains what compounding pharmacists do, and how their work relates to primary care and the glucagon-like peptide-1 receptor agonist drugs (GLP-1 RA drugs) for diabetes and obesity, which have become pharmaceutical blockbusters.


Related to this article

Why is healthcare spending declining in 2026? ©Kuzmick - stock.adobe.com
Health care was the only one of five sectors to cut spending commitments this spring, falling 2.8% as hospitals faced rising supply costs and physicians awaited the final 2027 Medicare fee schedule, Coupa's Business Spend Index found.